ORBIMED ADVISORS LLC Insider Trading for December 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of ORBIMED ADVISORS LLC for December 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30 2020 | ALPN | ALPINE IMMUNE SCIE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 14.25 | 600,000 | 8,550,000 | 3,070,955 | 3.7 M to 3.1 M (-16.34 %) |
| Dec 10 2020 | ARPO | Aerpio Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | X | 0.96 | 21,400 | 20,544 | 0 | |
| Dec 10 2020 | ARPO | Aerpio Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.96 | 21,400 | 41,944 | 0 | 21.4 K to 0 (-100.00 %) |
| Dec 10 2020 | ARPO | Aerpio Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | X | 0.96 | 21,400 | 20,544 | 21,400 | 0 to 21.4 K |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Option Exercise | C | 0.00 | 24,555 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Option Exercise | C | 0.00 | 9,461 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Option Exercise | C | 0.00 | 50,501 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Option Exercise | C | 0.00 | 118,398 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Option Exercise | C | 0.00 | 2,651,042 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Option Exercise | C | 0.00 | 243,494 | 0 | 0 | ||
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Buy | C | 0.00 | 24,637 | 0 | 84,599 | 60 K to 84.6 K (+41.09 %) | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Buy | C | 0.00 | 9,461 | 0 | 59,962 | 50.5 K to 60 K (+18.73 %) | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Buy | C | 0.00 | 50,501 | 0 | 50,501 | 0 to 50.5 K | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Buy | C | 0.00 | 118,794 | 0 | 3,313,330 | 3.2 M to 3.3 M (+3.72 %) | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Buy | C | 0.00 | 2,651,042 | 0 | 3,194,536 | 543.5 K to 3.2 M (+487.78 %) | |
| Dec 09 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Buy | C | 0.00 | 243,494 | 0 | 543,494 | 300 K to 543.5 K (+81.16 %) | |
| Dec 08 2020 | SBTX | Silverback Therape ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 3,918,279 | 0 | 0 | |
| Dec 08 2020 | SBTX | Silverback Therape ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 3,918,279 | 0 | 0 | |
| Dec 08 2020 | SBTX | Silverback Therape ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 9,259,259 | 0 | 0 | |
| Dec 08 2020 | SBTX | Silverback Therape ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 9,259,259 | 0 | 0 | |
| Dec 08 2020 | SBTX | Silverback Therape ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 12,857,142 | 0 | 0 | |
| Dec 08 2020 | SBTX | Silverback Therape ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 12,857,142 | 0 | 0 | |
| Dec 08 2020 | SBTX | Silverback Therape ... | ORBIMED ADVISORS LLC | Director | Buy | P | 21.00 | 952,377 | 19,999,917 | 952,377 | 0 to 952.4 K |
| Dec 08 2020 | SBTX | Silverback Therape ... | ORBIMED ADVISORS LLC | Director | Buy | P | 21.00 | 952,377 | 19,999,917 | 952,377 | 0 to 952.4 K |
| Dec 08 2020 | SBTX | Silverback Therape ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,055,287 | 0 | 7,519,188 | 6.5 M to 7.5 M (+16.33 %) |
| Dec 08 2020 | SBTX | Silverback Therape ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,055,287 | 0 | 7,519,188 | 6.5 M to 7.5 M (+16.33 %) |
| Dec 08 2020 | SBTX | Silverback Therape ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 2,493,741 | 0 | 6,463,901 | 4 M to 6.5 M (+62.81 %) |
| Dec 08 2020 | SBTX | Silverback Therape ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 2,493,741 | 0 | 6,463,901 | 4 M to 6.5 M (+62.81 %) |
| Dec 08 2020 | SBTX | Silverback Therape ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 3,462,737 | 0 | 3,970,160 | 507.4 K to 4 M (+682.42 %) |
| Dec 08 2020 | SBTX | Silverback Therape ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 3,462,737 | 0 | 3,970,160 | 507.4 K to 4 M (+682.42 %) |
| Dec 08 2020 | SBTX | Silverback Therape ... | ORBIMED ADVISORS LLC | Director | Buy | P | 21.00 | 238,100 | 5,000,100 | 507,423 | 269.3 K to 507.4 K (+88.41 %) |
| Dec 08 2020 | SBTX | Silverback Therape ... | ORBIMED ADVISORS LLC | Director | Buy | P | 21.00 | 238,100 | 5,000,100 | 507,423 | 269.3 K to 507.4 K (+88.41 %) |
| Dec 04 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Buy | P | 20.00 | 450,000 | 9,000,000 | 450,000 | 0 to 450 K | |
| Dec 04 2020 | KNTE | Kinnate Biopharma ... | ORBIMED ADVISORS LLC | Buy | P | 20.00 | 300,000 | 6,000,000 | 300,000 | 0 to 300 K |